064550 — Bioneer Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Market Cap
KR₩263bn
Enterprise Value
KR₩291bn
Revenue
KR₩330bn

Annual balance sheet for Bioneer, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	79,676	80,035	43,285	54,242	90,942
Net Total Accounts Receivable
Net Total Receivables	22,061	13,957	12,495	15,223	14,262
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	136,388	134,086	147,680	148,504	148,807
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	113,538	151,534	151,918	170,430	161,798
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	262,418	298,737	315,487	332,185	369,884
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	50,785	36,237	53,739	65,591	66,057
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	59,370	62,735	91,611	118,267	160,200
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	203,049	236,002	223,876	213,918	209,684
Total Liabilities & Shareholders' Equity	262,418	298,737	315,487	332,185	369,884
Total Common Shares Outstanding